Gr Sarantis (SAR) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
13 Jun, 2025Executive summary
Net Sales for the nine months ended September 30, 2024, reached €452.0m, up 27.9% year-over-year, including Stella Pack.
Comparable Net Sales (excluding Stella Pack) rose 11.3% to €393.3m, reflecting strong organic growth.
Integration of Stella Pack is progressing as planned, supporting both organic and inorganic growth.
Continued focus on digitalization, efficiency, and core category investment is fueling sustainable growth.
Financial highlights
Reported EBITDA increased 31.7% to €63.0m, with margin up to 13.9% (+41bps) year-over-year.
Reported EBIT rose 29.9% to €48.1m, with EBIT margin at 10.6% (+16bps) year-over-year.
Comparable EBITDA (excluding Stella Pack) up 14.3% to €54.7m; margin at 13.9% (+37bps).
Comparable EBIT up 15.1% to €42.6m; margin at 10.8% (+36bps).
Net Debt stood at €12.4m as of September 30, 2024.
Outlook and guidance
On track to deliver full-year 2024 guidance as communicated during March 2024 Investor Day.
Management remains focused on growth trajectory and strategic execution into year-end.
Latest events from Gr Sarantis
- EBITDA and net income surged in 2025, led by branded and beauty growth and global expansion.SAR
H2 202512 Mar 2026 - Record H1 sales and profit growth, fueled by Stella Pack and strong margin expansion.SAR
H1 202422 Jan 2026 - Record sales and profit growth in 2024, with further gains and investments forecast for 2025.SAR
H2 202424 Dec 2025 - Profitability rose despite a slight sales dip, driven by margin expansion and US growth initiatives.SAR
Q3 2025 TU23 Oct 2025 - Net profit up 20% to €29.2m on 0.5% sales growth, led by Beauty, Skin & Sun Care.SAR
H1 202512 Sep 2025